Paper46620
Lipoteichoic acids: a new class of bacterial antigen.
Wicken AJ and 1 other. Science, 1975. Cited by 321 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Lipoteichoic acids: a new class of bacterial antigen. Papers, record 46620. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/46620
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Bacterial | Major topic |
| Bacteria | Major topic |
| Teichoic Acids | Major topic |
| Antibody Specificity | |
| Cell Membrane | |
| Chemical Phenomena | |
| Chemistry | |
| Cross Reactions | |
| Epitopes | |
| Glycolipids | |
| Lactobacillus | |
| Lipopolysaccharides | |
| Models, Molecular | |
| Molecular Conformation | |
| Phospholipids | |
| Streptococcus |
Source PubMed
Cited by120
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 321 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,854,428 | Genome-wide screen identifies novel factors for surface protein cross-wall trafficking and cell envelope homeostasis in Staphylococcus aureus. | J Bacteriol | 2026 | https://conductscience.org/library/papers/41854428 | PubMed |
| 41,279,803 | Genome-wide screen identifies novel factors for surface protein cross-wall trafficking and cell envelope homeostasis in Staphylococcus aureus. | bioRxiv | 2025 | https://conductscience.org/library/papers/41279803 | PubMed |
| 30,744,121 | Immunostimulatory Phosphatidylmonogalactosyldiacylglycerols (PGDG) from the Marine Diatom Thalassiosira weissflogii: Inspiration for a Novel Synthetic Toll-Like Receptor 4 Agonist. | Mar Drugs | 2019 | https://conductscience.org/library/papers/30744121 | PubMed |
| 29,786,250 | [Effect of staphylococcal lipoteichoic acid on differentiation of RAW264.7 cells into osteoclasts]. | Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi | 2017 | https://conductscience.org/library/papers/29786250 | PubMed |
| 28,852,794 | Microbiology neutralization of zearalenone using Lactococcus lactis and Bifidobacterium sp. | Anal Bioanal Chem | 2018 | https://conductscience.org/library/papers/28852794 | PubMed |
| 26,431,539 | Endocytosis‒Mediated Invasion and Pathogenicity of Streptococcus agalactiae in Rat Cardiomyocyte (H9C2). | PLoS One | 2015 | https://conductscience.org/library/papers/26431539 | PubMed |
| 25,714,744 | Two host clades, two bacterial arsenals: evolution through gene losses in facultative endosymbionts. | Genome Biol Evol | 2015 | https://conductscience.org/library/papers/25714744 | PubMed |
| 25,090,957 | Characterization of lipoteichoic acid structures from three probiotic Bacillus strains: involvement of D-alanine in their biological activity. | Antonie Van Leeuwenhoek | 2014 | https://conductscience.org/library/papers/25090957 | PubMed |
| 24,259,411 | Covalently coupled immunostimulant heterodimers. | Angew Chem Int Ed Engl | 2014 | https://conductscience.org/library/papers/24259411 | PubMed |
| 17,954,723 | Lipoteichoic acid is important in innate immune responses to gram-positive bacteria. | Infect Immun | 2008 | https://conductscience.org/library/papers/17954723 | PubMed |
| 16,545,511 | Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunisations. | Vaccine | 2006 | https://conductscience.org/library/papers/16545511 | PubMed |
| 16,166,534 | D-alanylation of teichoic acids promotes group a streptococcus antimicrobial peptide resistance, neutrophil survival, and epithelial cell invasion. | J Bacteriol | 2005 | https://conductscience.org/library/papers/16166534 | PubMed |
| 16,138,192 | Blood-brain barrier invasion by group B Streptococcus depends upon proper cell-surface anchoring of lipoteichoic acid. | J Clin Invest | 2005 | https://conductscience.org/library/papers/16138192 | PubMed |
| 14,665,680 | A continuum of anionic charge: structures and functions of D-alanyl-teichoic acids in gram-positive bacteria. | Microbiol Mol Biol Rev | 2003 | https://conductscience.org/library/papers/14665680 | PubMed |
| 12,904,427 | Ability of lysozyme and 2-deoxyglucose to differentiate human and bovine Streptococcus bovis strains. | J Clin Microbiol | 2003 | https://conductscience.org/library/papers/12904427 | PubMed |
| 11,527,813 | Lipoteichoic acid inhibits interleukin-2 (IL-2) function by direct binding to IL-2. | Clin Diagn Lab Immunol | 2001 | https://conductscience.org/library/papers/11527813 | PubMed |
| 10,620,613 | Protection from lethal gram-positive infection by macrophage scavenger receptor-dependent phagocytosis. | J Exp Med | 2000 | https://conductscience.org/library/papers/10620613 | PubMed |
| 10,049,865 | Cell surface-associated lipoteichoic acid acts as an adhesion factor for attachment of Lactobacillus johnsonii La1 to human enterocyte-like Caco-2 cells. | Appl Environ Microbiol | 1999 | https://conductscience.org/library/papers/10049865 | PubMed |
| 9,670,043 | Mechanism of gram-positive shock: identification of peptidoglycan and lipoteichoic acid moieties essential in the induction of nitric oxide synthase, shock, and multiple organ failure. | J Exp Med | 1998 | https://conductscience.org/library/papers/9670043 | PubMed |
| 9,603,887 | D-Alanylcardiolipin, a major component of the unique lipid pattern of Vagococcus fluvialis. | J Bacteriol | 1998 | https://conductscience.org/library/papers/9603887 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/46620
GET https://conductscience.org/api/papers/v1/46620/cited_by?page=2